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Determining the Natural Distribution of 24 Hour Bilirubin Levels in Term, Exclusively
Breastfed Newborns
Lauren Greenawald, DO, Alexis Newton, MD, Michael D. Schwartz, MD, Gwendolyn Chung, MD, Greg Floyd, MBA
Lehigh Valley Health Network, Allentown, Pennsylvania
BACKGROUND
Newborn bilirubin levels are routinely measured as hyperbilirubinemia can be neurologically devastating, causing kernicterus
in infants. The American Academy of Pediatrics (AAP) recommended clinical evaluation of jaundice in all term infants at 24
hours of life and consideration of a routine serum bilirubin prior to discharge. Bhutani et. al. in 1999 developed a nomogram
to categorize full-term infant bilirubin levels based on hours of life and total serum level. These values were stratified into
high, high-intermediate, low-intermediate and low risk levels to determine the need of follow up evaluation or treatment. The
AAP acknowledges breastfed infants might require closer monitoring, as they can be at higher risk for hyperbilirubinemia.
The Bhutani-AAP nomogram was developed using a population of only 49.5% exclusively breast fed infants and 59.2% with
any breast feeding.

HYPOTHESIS

RESULTS
Table 1: Demographics Based on Feeding Patterns
Subset BF: exclusively breastfed

567

55.3%

6.11

1.76

Subset FF: exclusively formula fed

195

19.0%

5.99

1.95

Subset F>30: >30mL formula in 1st 24 hrs

180

17.5%

6.33

1.81

Subset F <30: <30mLR formuLRa in 1st 24 hrs

84

8.2%

6.42

1.76

55.3% of infants analyzed were exclusively breast fed, and 81% had
any breastfeeding.

Exclusively breastfed infants will have higher bilirubin levels within the first 24 hours of life compared with the current
standard reference values.

Table 2: Exclusiuvely Breastfed infant Risk Stratification and PPV
Risk Level at 24
Hours

METHODS
A retrospective electronic chart review of full term infants born at Lehigh Valley Hospital from July 2013 to December 2013
under the service of ABC Pediatrics of Lehigh Valley Physician Group.
Inclusion Criteria:
1. Gestational age at least 35 weeks weighing at least 2500 grams OR gestational age 36 weeks weighing at least > 2000 grams.

Exclusion Criteria:
1. Infants transferred to NICU by 24 hours of life
2. The use of phototherapy in the first 24 hours of life

24 hour bilirubin level, feeding type, and need for phototherapy during newborn admission were recorded for the 1026
eligible infants. These infants were stratified based on feeding types: breastfed, formula 30 mls and formula fed infants.
A total of 770 full term infants had outpatient follow up care performed by ABC-LVPG-Pediatrics and were evaluated for the
development of any subsequent hyperbilirubinemia.
Each bilirubin was stratified to risk per the classification of the AAP-Bhutani nomogram. All subsequent assessed bilirubin
values were then assessed based on the hours of life at which they were obtained, and need for phototherapy. Positive
Predictive Value was calculated, as defined by Bhutani et al, as predicting the risk of any subsequent high risk bilirubin.

Figure1. Distribution of breastfed infants compared
to those in the Bhutani Nomogram

Number Infants/
Percentage of Population

Subsequent High
Risk Bilirubin

PPV

High risk

102/18.0%

37

36.3%

High Intermediate

170/30.0%

4

2.4%

Low Intermediate

172/30.0%

1

0.1%

Low

125/22.5%

0

0.00%

48% of exclusively breastfed infants had high or high intermediate risk
stratification at 24 hours of life. The Positive Predictive Value for high
risk exclusively breast fed infants, for the development of a subsequent
high risk bilirubin phototherapy, of 38.25% is very close to Bhutani
et.al of 39.5%. However, the PPV of 2.4% for the high intermediate risk
strata is much lower than Bhutani et. al. report of 12.9%.
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14% of exclusively breastfed infants were high risk at 24 hours
and 45% were high intermediate risk level. This was significantly
higher than the 5% high risk and 25% high intermediate risk
defined by Bhutani et al. (1999).

CONCLUSIONS
The data supports the hypothesis that breastfed infants have
higher bilirubin levels in the first 24 hours of life than predicted
by the Bhutani-AAP nomogram. Furthermore, though the PPV of a
high risk bilirubin was substantial, only 2.4% of high intermediate
risk values developed subsequent significant hyperbilirubinemia.
These results are significant, as more accurate classification
of risk would decrease the need and cost of subsequent
laboratory evaluation. Further studies are recommended to
create a specific nomogram and risk stratification for breastfed
infants. The current Bhutani –AAP system does not accurately
reflect or predict the natural history of bilirubin rise in breast fed
infants.
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